Medtronic has received CE mark approval for its 31mm CoreValve System, a transcatheter aortic valve to treat patients with symptomatic, severe aortic stenosis.
The CoreValve System provides a minimally invasive treatment option without open-heart surgery.
The CoreValve System can be compressed into a small delivery system and is deployed through the same 18Fr (less than 1/4-inch or approximately 6mm in diameter) delivery system as smaller CoreValve sizes.
St Georg Hamburg Asklepios Klinik professor Ulrich Schafer said they have seen positive clinical outcomes with the CoreValve System and are pleased to offer it to individuals who, until now, have been denied transcatheter aortic valve implantation due to their larger native valve size
The CoreValve System is also available in 26mm, 29mm sizes, based on the self-expanding platform.